Clinical Trial Update: Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration

View source ↗

Summary

This clinical trial update assesses how accurately subjects used the Rebiject II injection device for multiple sclerosis in a 10-step dummy demonstration, as ev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Rebiject II Injection Device

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Status: COMPLETED